Fundacion CITA Alzheimer — Clinical Trial Site

8 Registered trials

1 Currently recruiting

Organisation

Fundacion CITA Alzheimer

Location

Donostia, Spain

Identifier

ORG-100049309

Address

Pasealeku Mikeletegi 71, 20009, Spain

Departments

Fundacion CITA-Alzheimer
N/A
Neurología
Neurology

Clinical trials at this site (8)

Search interface

The LESS-AD trial: A study on the use of levetiracetam to prevent seizures in adults with Down syndrome and Alzheimer's disease. Recruiting

2024-516148-24-00 Down syndrome 5 2025-12-16
AHEAD 3-45 Study: A Clinical Study to Investigate the Effects of BAN2401 in Subjects With Preclinical Alzheimer’s Disease Ended

2024-510888-39-00 Early Preclinical Alzheimer’s Disease and Intermediate 5 2021-07-21
A Phase 3 clinical study to investigate the effects of BAN2401 in patients with Early Alzheimer's Disease. Ended

2024-510887-22-00 Mild cognitive impairment due to Alzheimer's disease or 5 2019-09-30
Hero: A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of ION269 in Participants With Down Syndrome (DS) at Risk for … Ended

2023-509257-31-00 Alzheimer’s Disease in Individuals with Down Syndrome 1 2025-02-12
EFFICACY AND SAFETY OF GSK4527226 [AL101] IN PATIENTS WITH EARLY ALZHEIMER’S DISEASE Ended

2023-505083-11-01 Alzheimer's Disease 4 2024-05-07
A Randomized, Placebo-Controlled, Double-Blind Study of XPro1595 in Patients with Early Alzheimer’s Disease with Biomarkers of Inflammation Ended

2023-505396-71-00 Early Alzheimer’s Disease with Biomarkers of Inflammati 4 2024-03-01
A Long-term Extension Study to Evaluate Safety, Tolerability, and Efficacy of AL002 in Alzheimer's Disease Ended

2023-506872-29-00 Alzheimer's Disease 4 2023-04-13
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE) Ended

2023-506919-18-00 Mild cognitive impairment (MCI) or mild dementia, both 5 2021-05-17